TickerFactsScreenerDevelopers

Transcode Therapeutics, Inc. (RNAZ) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2020: -$493.0K2021: -$5.27M2022: -$15.76M2023: -$18.07M2024: -$13.34M2025: -$19.52M-$19.52M
2020Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$19.52M-46.3%
2024-$13.34M+26.2%
2023-$18.07M-14.7%
2022-$15.76M-199.3%
2021-$5.27M-968.4%
2020-$493.0K—